Browse drugs

…r, there is no clear consensus on which patients should receive amiodarone therapy. Instead, guidelines recommend that it should be consid…

…Background/Introduction Amiodarone is a widely used class III anti-arrhythmic drug that is highly …

… TA 733. Available from: https://www.nice.org.uk/guidance/ta733 Icosapent ethyl with statin therapy for reducing the risk of cardiovascular eve…

…ortantly, we found that timing is crucial, as administration of IL-2cx after (but not before) ICIs led to profound antitumor effects. …

…raftment of immune populations in a humanized model.Conclusions AZD5863 mediates potent anti-tumor activity in vitro and in vivo, while…

…subfield thickness (CST) (390.13 µm vs 334.20 µm, p=0.033) than aflibercept patients. Baseline HbA1c (p=0.012) and number of bevacizumab in…

…induction chemotherapy and CCRT, oral chemotherapy, either with capecitabine or S-1, was efficacious and tolerable.…

…radiation (p < 0.001) and procedure time (p < 0.001).Conclusion SwiftPAC coils are a novel embolic agent that provide a comparable cSDH treatm…

…J&J, Imperative Care, Stryker; ownership/investment interest in Vastrax, Q’Apel, Spartan Micro, Synchron, Endostream. A. Puri: 6; C; Dr…

…unctional outcome, but functional outcomes were similar between Tenecteplase and alteplase overall.Conclusions We observed higher early repe…

…ics such as recombinant tissue plasminogen activator (rtPA) and tirofiban have shown potential as adjunctive therapies. The aim of this s…

…6% vs 51%, p=0.003), including after treatment discontinuation. Avacopan was associated with accelerated glucocorticoid tapering (≤5 mg/…